⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2024Diabetes Obesity and Metabolism

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

Gong Feng Na He Jing Gao Xiao‐Cheng Li Fenna Zhang Chengcheng Liu Giovanni Targher Christopher D. Byrne Man Mi Ming‐Hua Zheng Feng Ye

View Full Paper

Ask AI

Bookmark

Share

Abstract

Non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease (MAFLD) remain challenging. We aimed to identify novel key genes as non-invasive biomarkers for MAFLD, elucidate causal relationships between biomarkers and MAFLD and determine the role of immune cells as potential mediators.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Feng et al. (2024) studied this question.

synapsesocial.com/papers/68e5969ab6db643587531903 https://doi.org/10.1111/dom.15925

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immune metabolic changes identify causal candidate genes and enable diagnostic frameworks in MAFLD2025
2Immune cells and blood lipids mediation: a Mendelian randomization study on metabolic dysfunction-associated fatty liver disease2024
3Identifying Causal Relations between Gut Microbiome, Metabolic Dysfunction-Associated Fatty Liver Disease and the Novel Mediators of Blood Metabolites2024 · 2 citations
4Causal relationship between metabolic dysfunction-associated fatty liver disease and endotoxin biomarkers: A Mendelian randomization studyother · 2025 · 2 citations
5Identification of Key Genes Related to Both Lipid Metabolism Disorders and Inflammation in MAFLD2025 · 1 citations